EDGAR Filing Documents for 0001144204-17-011451

Form S-4/A - Registration of securities, business combinations: [Amend]

SEC Accession No. 0001144204-17-011451

Filing Date

2017-02-28

Accepted

2017-02-27 20:16:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-4/A	v460371_s4a.htm	S-4/A	5105247
2	EXHIBIT 5.1	v460371_ex5-1.htm	EX-5.1	11542
3	EXHIBIT 23.1	v460371_ex23-1.htm	EX-23.1	2089
4	EXHIBIT 23.2	v460371_ex23-2.htm	EX-23.2	2268
5	EXHIBIT 99.2	v460371_ex99-2.htm	EX-99.2	652
6	EXHIBIT 99.3	v460371_ex99-3.htm	EX-99.3	11448
7	EXHIBIT 99.9	v460371_ex99-9.htm	EX-99.9	2770
8	GRAPHIC	line.gif	GRAPHIC	43
9	GRAPHIC	spacer.gif	GRAPHIC	43
10	GRAPHIC	logo_dipexium.jpg	GRAPHIC	58140
11	GRAPHIC	logo_plx-pharma.jpg	GRAPHIC	46875
12	GRAPHIC	v457129_chrt-aspirin.jpg	GRAPHIC	195842
13	GRAPHIC	v457129_chrt-bar.jpg	GRAPHIC	83508
14	GRAPHIC	v457129_chrt-bar2.jpg	GRAPHIC	58763
15	GRAPHIC	v457129_chrt-bar3.jpg	GRAPHIC	68078
16	GRAPHIC	v457129_chrt-bar4.jpg	GRAPHIC	100223
17	GRAPHIC	v457129_chrt-flow.jpg	GRAPHIC	298170
18	GRAPHIC	v457129_chrt-flow2.jpg	GRAPHIC	62472
19	GRAPHIC	v457129_chrt-line.jpg	GRAPHIC	135284
20	GRAPHIC	v457129_chrt-line2.jpg	GRAPHIC	375418
21	GRAPHIC	v457129_chrt-line3.jpg	GRAPHIC	97073
22	GRAPHIC	v457129_img-slide5.jpg	GRAPHIC	453368
23	GRAPHIC	v457129_img-slide6.jpg	GRAPHIC	469289
24	GRAPHIC	pg1img1_ex5-1.jpg	GRAPHIC	5363
25	GRAPHIC	v460371_imgex99x2.jpg	GRAPHIC	320531
	Complete submission text file	0001144204-17-011451.txt		9033644

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005

Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834

Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)